World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
53
Citations
13433
World Ranking
2370
National Ranking
1172

Overview

Andrei Goga is affiliated with the University of California, San Francisco in the United States. Their research focuses primarily on biochemistry, genetics, molecular biology, and medicine, with a significant emphasis on oncology and cancer research. They have contributed extensively to areas such as cancer immunotherapy, biomarkers, cancer hypoxia and metabolism, cancer cells and metastasis, cancer diagnosis and treatment, genomics and diagnostics, molecular pathways related to cancer, and advanced breast cancer therapies.

Their scholarly output includes papers published between 2020 and 2022 in a variety of notable journals. Key publications include:

  • MicroRNA-342-3p is a potent tumour suppressor in hepatocellular carcinoma, 2020, Journal of Hepatology
  • Ribosome stalling during selenoprotein translation exposes a ferroptosis vulnerability, 2022, Nature Chemical Biology
  • Host and gut bacteria share metabolic pathways for anti-cancer drug metabolism, 2022, Nature Microbiology
  • MYC Dysregulates Mitosis, Revealing Cancer Vulnerabilities, 2020, Cell Reports
  • Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer, 2022, Nature Communications

Goga's frequent coauthors indicate collaboration with researchers active in cancer biology and immunology. Among them are Hope S. Rugo, Joyce V. Lee, Juliane Winkler, Pauliina Munne, and Juha Klefström.

The scientist's publication record is concentrated in several venues with multiple contributions. These include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancer Research
  • Journal of Clinical Oncology
  • Nature Communications
  • Journal of Hepatology

Their work spans highly specialized subfields such as oncology, cancer research, molecular biology, immunology, and pulmonary and respiratory medicine. The focus on cancer encompasses molecular pathways, immunotherapy approaches, and clinical aspects of disease management and diagnostics.

Best Publications

  • Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells.

    Devon A. Lawson;Nirav R. Bhakta;Kai Kessenbrock;Kai Kessenbrock;Karin D. Prummel

  • Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b.

    Gary K. Scott;Andrei Goga;Dipa Bhaumik;Crystal E. Berger

  • IRE1α Cleaves Select microRNAs During ER Stress to Derepress Translation of Proapoptotic Caspase-2

    John-Paul Upton;Likun Wang;Dan Han;Eric S. Wang

  • Nanodiamond Therapeutic Delivery Agents Mediate Enhanced Chemoresistant Tumor Treatment

    Edward K. Chow;Xue-Qing Zhang;Mark Chen;Robert Lam

  • Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets

    Justin M. Balko;Jennifer M. Giltnane;Kai Wang;Luis J. Schwarz

  • Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer

    Roman Camarda;Alicia Y Zhou;Rebecca A Kohnz;Sanjeev Balakrishnan

  • Hepatic Stem-like Phenotype and Interplay of Wnt/β-Catenin and Myc Signaling in Aggressive Childhood Liver Cancer

    Stefano Cairo;Stefano Cairo;Carolina Armengol;Carolina Armengol;Aurélien de Reyniès;Yu. Wei;Yu. Wei

  • Comprehensive analysis of normal adjacent to tumor transcriptomes.

    Dvir Aran;Roman Camarda;Justin Odegaard;Hyojung Paik;Hyojung Paik

  • Short RNA duplexes produced by hydrolysis with Escherichia coli RNase III mediate effective RNA interference in mammalian cells.

    Dun Yang;Frank Buchholz;Zhongdong Huang;Andrei Goga

  • Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia.

    T. R. Golub;A. Goga;G. F. Barker;D. E. H. Afar

  • MYC Pathway Activation in Triple-Negative Breast Cancer Is Synthetic Lethal With CDK Inhibition

    Dai Horiuchi;Leonard Kusdra;Noelle E. Huskey;Sanjay Chandriani;Sanjay Chandriani

  • Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC

    Andrei Goga;Dun Yang;Aaron D Tward;David O Morgan

  • Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene

    Andrei Goga;Jami McLaughlin;Daniel E.H Afar;Douglas C Saffran

  • Profiling human breast epithelial cells using single cell RNA sequencing identifies cell diversity

    Quy H. Nguyen;Nicholas Pervolarakis;Kerrigan Blake;Dennis Ma

  • Differential complementation of Bcr-Abl point mutants with c-Myc

    Daniel E. H. Afar;Andrei Goga;Jami McLaughlin;Owen N. Witte

  • Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state

    Jürgen den Hollander;Sara Rimpi;Joanne R. Doherty;Martina Rudelius

  • 13C-Pyruvate Imaging Reveals Alterations in Glycolysis that Precede c-Myc-Induced Tumor Formation and Regression

    Simon Hu;Asha Balakrishnan;Robert A. Bok;Brittany Anderton

  • Up-regulation of miR-21 by HER2/neu Signaling Promotes Cell Invasion *

    Tzu Hsuan Huang;Fangting Wu;Gabriel B. Loeb;Ruby Hsu

  • Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer.

    Khyati N. Shah;Roma Bhatt;Julia Rotow;Julia Rohrberg

  • miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma

    Alexander Swarbrick;Alexander Swarbrick;Susan L Woods;Susan L Woods;Alexander Shaw;Alexander Shaw;Alexander Shaw;Asha Balakrishnan

Frequent Co-Authors

Hope S. Rugo
Hope S. Rugo University of California, San Francisco
Kevan M. Shokat
Kevan M. Shokat University of California, San Francisco
Christina Yau
Christina Yau University of California, San Francisco
Daniel K. Nomura
Daniel K. Nomura University of California, Berkeley
John W. Park
John W. Park University of California, San Francisco
Zena Werb
Zena Werb University of California, San Francisco
Stuart L. Schreiber
Stuart L. Schreiber Harvard University
Frank McCormick
Frank McCormick University of California, San Francisco
Daniel B. Vigneron
Daniel B. Vigneron University of California, San Francisco
Owen N. Witte
Owen N. Witte University of California, Los Angeles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Molecular Biology in the USA can open doors to numerous online degrees and career paths in healthcare and research fields. Many students consider bridging degrees that can speed up their career advancement, such as the fastest rn to bsn program for registered nurses. These accelerated programs allow learners to transition efficiently into more specialized roles and can often be completed in less than a year.

If you’re aiming for an advanced nursing role, understanding the how long does it take to become a nurse practitioner timeline is crucial. Some options, such as the adn to np bridge programs, provide a direct and efficient route from an associate degree in nursing to a nurse practitioner credential.

For those interested in psychiatric and mental health fields, understanding the psych np salary landscape by state can help you plan your future career and earning potential. With so many flexible online pathways, students of molecular biology can access a wide range of rewarding healthcare and research professions.

Best Scientists Citing Andrei Goga

Trending Scientists

Recently Published Articles